Skip to search formSkip to main contentSkip to account menu

RHINITIS MEDICAMENTOSA

Known as: RHINITIS MEDICAMENTOUS 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

RhinitisRhinorrhea

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Management of Rhinitis Medicamentosa: A Systematic Review
Objective Rhinitis medicamentosa (RM) is a common condition resulting from overuse of topical nasal decongestants. Despite the… 
Review
2009
Review
2009
Rhinitis medicamentosa: what an otolaryngologist needs to know
Rhinitis medicamentosa (RM) is a drug induced non-allergic rhinitis associated with prolonged use of topical nasal decongestants… 
Review
2009
Review
2009
Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants.
AIM The aim of this study was to investigate the frequency of rhinitis medicamentosa (RM) in patients attending the ENT… 
2008
2008
Rhinitis Medicamentosa: Therapeutic Effect of Diode Laser Inferior Turbinate Reduction on Nasal Obstruction and Decongestant Abuse
Background The purpose of this study was to evaluate long-term outcomes of an outpatient-based diode laser inferior turbinate… 
2007
2007
Rhinitis medicamentosa: Electron microscopic changes of human nasal mucosa
Review
2006
Review
2006
Rhinitis medicamentosa.
Rhinitis medicamentosa (RM) is a condition induced by overuse of nasal decongestants. The term RM, also called rebound or… 
Review
2005
Review
2005
Rhinitis Medicamentosa
Rhinitis medicamentosa (RM) is a drug-induced, nonallergic form of rhinitis that is associated with prolonged use of topical… 
2004
2004
Mucosal Changes in Rhinitis Medicamentosa
To evaluate the nasal mucosal changes in rhinitis medicamentosa (RM), especially those related to goblet cells and subepithelial… 
Review
1999
Review
1999
Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa.
Highly Cited
1997
Highly Cited
1997
Rbtis medicamentosa: aspects of pathophysiology and treatment
With modern vasoconstrictors, such as oxy‐ and xylometazoline, the risk of developing rhinitis medicamentosa (RM) has been… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)